Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Annual Revenue ($)
Novartis revenue was $52.88 b in FY, 2021
| FY, 2018 | FY, 2019 | FY, 2020 | FY, 2021 | |
|---|---|---|---|---|
| Revenue | $53.17 b | $50.49 b | $49.9 b | $52.88 b |
Revenue Breakdown
Business Segment
Geographic Segment
Novartis revenue breakdown by business segment: 18.3% from SANDOZ and 81.7% from INNOVATIVE MEDICINES
Novartis revenue breakdown by geographic segment: 5.2% from JAPAN, 9.4% from GERMANY, 32.6% from UNITED STATES, 40.3% from OTHER/GROUPS, 5.9% from CHINA (PEOPLES REPUBLIC) and 6.6% from Other
| FY, 2021 | FY, 2020 | FY, 2018 | FY, 2019 | |
|---|---|---|---|---|
| ELIMINATIONS | ($964 k) | ($813 k) | ($906 k) | ($847 k) |
| SANDOZ | $9.87 m | $9.89 m | $10.1 m | $9.94 m |
| INNOVATIVE MEDICINES | $43.97 m | $40.82 m | $36.82 m | $39.59 m |
| ALCON, INC. | $7.15 m |
| FY, 2021 | FY, 2020 | FY, 2018 | FY, 2019 | |
|---|---|---|---|---|
| REST OF WORLD | $22.17 m | $1.23 m | ||
| SWITZERLAND | $873 k | $800 k | $852 k | $848 k |
| JAPAN | $2.68 m | $2.8 m | $3.17 m | $2.66 m |
| GERMANY | $4.87 m | $4.52 m | $4.18 m | $4.12 m |
| FRANCE | $2.52 m | $2.44 m | $2.71 m | $2.44 m |
| UNITED STATES | $16.82 m | $16.48 m | $17.56 m | $16.28 m |
| OTHER/GROUPS | $20.81 m | $21.61 m | $1.27 m | $21.1 m |
| UNITED KINGDOM | $1.26 m | |||
| CHINA (PEOPLES REPUBLIC) | $3.05 m |
Need Data?
Craft can deliver 250+ data points of financial, operating, and human capital indicators on companies via API.